Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2010; 16(46): 5830-5837
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830
Table 5 Occurrence of the wt and the mutated form of peroxisome proliferator-activated receptor-γ2 depending on the grade of steatosis and ballooning n (%)
| Steatosis | Ballooning | |||||||||||
| NAFLD | AFLD | NAFLD | AFLD | |||||||||
| Total | Moderate (0-1) | Severe (2-3) | Total | Moderate (0-1) | Severe (2-3) | Total | - | + | Total | - | + | |
| Allelic discrimination | ||||||||||||
| Mutation | 66 (100) | 27 (41) | 39 (59) | 26 (100) | 12 (46) | 14 (54) | 66 (100) | 28 (42) | 38 (58) | 26 (100) | 19 (73) | 7 (27) |
| Wild type | 460 (100) | 229 (50) | 231 (50) | 174 (100) | 88 (51) | 86 (49) | 460 (100) | 206 (45) | 254 (55) | 174 (100) | 121 (70) | 53 (30) |
| P value | 0.112 | 0.417 | 0.411 | 0.454 | ||||||||
| Odds ratio (CI) | 1.43 (0.85-2.42) | 1.19 (0.52-2.73) | 1.10 (0.65-1.85) | 0.84 (0.33-2.12) | ||||||||
- Citation: Rey JW, Noetel A, Hardt A, Canbay A, Alakus H, Hausen AZ, Dienes HP, Drebber U, Odenthal M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol 2010; 16(46): 5830-5837
- URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5830.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5830